3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ingersoll Rand's board approved an amended employment agreement with Chairman and CEO Vicente Reynal that extends his initial term to February 29, 2032, raises his base salary from $1.1 million to $1.2 million, and adds a performance-based equity award. The filing also reports that Senior Vice President Michael Weatherred retired effective immediately, and that Scott Watson and Shaun Carlson were promoted to group president roles. For shareholders, the new CEO award vests only if Adjusted EPS grows at a compound annual rate of at least 8% to 10% over five years.
Reynal's base salary rises from $1.1 million to $1.2 million; target bonus stays at 150% of base salary
Expected grant on November 23, 2026 of 226,098 performance stock units, valued at about $17.1 million, vesting on Adjusted EPS CAGR of 8% (50%) to 10% (100%) over 2027-2031
Michael Weatherred retired effective immediately after notice on October 27, 2026, and will serve in an advisory role through May 2028
Scott Watson and Shaun Carlson named senior vice presidents and group presidents, both internal promotions reporting to Reynal
Utz Brands disclosed that CEO Howard Friedman will leave the company after the merger with Intersnack-linked buyers closes, with his employment expected to end November 30, 2026, and that he will leave the board at closing. The company also said board member B. John Lindeman received an offer to become CEO of Utz's post-closing operating company, subject to closing and a written employment agreement.
Friedman's employment is expected to end November 30, 2026, contingent on the merger closing; he leaves the board at closing
Friedman said his decision was not due to any disagreement with the company, Parent, or continuing stockholders
Lindeman received a letter agreement on October 29, 2026 offering the CEO role at Company LLC, with a contemplated start of November 30, 2026
Special meeting of stockholders is scheduled for November 13, 2026; two stockholder complaints were filed October 22, 2026, which the company says are without merit
Equity LifeStyle Properties said Patrick Waite will succeed Marguerite Nader as President and Chief executive officer effective January 1, 2027, and Waite will also join the Board. Nader will remain on the Board as Executive Vice Chair, and David Eldersveld will become Chief Operating Officer, as part of a multi-year succession plan. The filing reports no financial results or guidance changes.
Nader ceases to be Vice Chairman and CEO on December 31, 2026 and becomes Executive Vice Chair of the Board on January 1, 2027.
Waite, 60, becomes President and CEO on January 1, 2027 and is elected to the Board, which increases from nine to ten directors.
Waite's approved 2027 base salary is $614,935, with bonus potential of 290% of base salary; Eldersveld's is $476,558, with bonus potential of 220%.
The Board declared a fourth quarter 2026 dividend of $0.5425 per share, payable January 8, 2027 to holders of record on December 24, 2026.
Verra Mobility said CFO Craig Conti will resign effective November 4, 2026. The Board appointed Matthew Kvarda, a Managing Director at Alvarez & Marsal, as interim CFO effective November 5, 2026, while a search firm assists in finding a permanent CFO. Kvarda's services are provided through an engagement with Alvarez & Marsal, which the company pays directly, and he will not receive compensation from Verra Mobility.
Craig Conti resigns as Executive Vice President and Chief Financial Officer effective November 4, 2026.
Matthew Kvarda, 56, is appointed interim CFO and principal financial officer effective November 5, 2026, until a permanent CFO is appointed.
Verra Mobility will pay Alvarez & Marsal $150,000 per month plus expenses, rising to $165,000 from May 1, 2027; fees through October 31, 2027 may not exceed $1,890,000 without consent.
Spencer Stuart is assisting the Board in the search for a permanent Chief Financial Officer.
Tempest Therapeutics said Chief Financial Officer Constance Ames resigned effective immediately on October 26, 2026, citing personal considerations unrelated to the company. The board appointed Stephanie Horn-Warnock as CFO, principal financial and accounting officer, treasurer and corporate secretary, also effective immediately, and she will work for the company as a consultant under an engagement letter dated October 28, 2026.
Constance Ames resigned as CFO and from all other company positions, effective immediately, for personal considerations unrelated to the company.
Stephanie Horn-Warnock, 37, was appointed CFO effective immediately on October 26, 2026.
Horn-Warnock previously was Vice President of Finance at ROM Technologies Inc. from January 2024 to September 2026.
Under her consulting engagement letter dated October 28, 2026, the company will pay $450 per hour plus expenses and an indirect cost allocation of 5.0% of total professional fees.
System1, Inc. said its President and Chief Operating Officer, Charles Ursini, resigned effective at the close of business on October 30, 2026. He will stay on the Board of Directors and serve as a strategic advisor to management, and the filing gives no replacement or financial details.
Charles Ursini resigned as President and Chief Operating Officer, effective close of business October 30, 2026
Ursini notified the company of the resignation on October 26, 2026
He had served as President and COO since April 2024
He will continue as a director and strategic advisor to management
NextCure said its Chief Medical Officer, Dr. Udayan Guha, will be terminated effective October 31, 2026, in connection with the pending merger with Avere Therapeutics, Inc. He signed a severance agreement and release, and additional change-in-control severance is payable only if the merger closes.
Dr. Udayan Guha, Chief Medical Officer and a named executive officer, is terminated effective October 31, 2026.
The departure is tied to the pending merger of NextCure and Avere Therapeutics, Inc.
Severance follows his existing employment agreement; enhanced change-in-control severance applies only if the merger closes.
The filing does not state the dollar amount of severance.
Genworth Financial said President and CEO Thomas J. McInerney will retire and leave its board effective December 31, 2026. Jerome T. Upton, the company's CFO, will become President and CEO and join the board effective January 1, 2027, and Angela R. Simmons will become Executive Vice President and CFO on the same date.
Thomas J. McInerney retires as President and CEO and resigns from the board effective December 31, 2026.
Jerome T. Upton, currently CFO, is to become President and CEO and a board member effective January 1, 2027.
Angela R. Simmons, currently CFO of the Closed Block, is to become Executive Vice President and CFO effective January 1, 2027.
The filing says McInerney's retirement is not the result of any disagreement with the company, and compensation terms for Upton and Simmons will be disclosed later by amendment.
Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board effective October 25, 2026, replacing Cheng Liu, Ph.D., who became Chief Scientific Officer while remaining President and a director. The filing also sets Pussinen's pay package, including a 1,000,000-share option grant and base salary increases tied to future financing, and says the Board adopted a plan to propose a change to its director class structure for stockholder vote in 2027.
Cynthia Pussinen, age 57, appointed CEO, Class I director and Board Chairperson effective October 25, 2026
Pussinen's base salary is $250,000, rising to $400,000, $450,000 and $525,000 as cumulative qualifying funding after October 25, 2026 exceeds $35.0 million, $55.0 million and $75.0 million
Option to purchase 1,000,000 shares granted on the second business day after the filing, with 25% vesting on October 25, 2027
Proposed amendment to Article V, Section A to be submitted to stockholders at the 2027 annual meeting
Shutterstock founder Jon Oringer returned as Chief Executive Officer and Chairman, effective October 28, 2026, replacing interim CEO Rik Powell, who remains Chief Financial Officer. Hichame Assi, CEO of the Company's Envato unit, was named President and Chief Operating Officer, and the company said it will not hold its scheduled third quarter 2026 earnings call on November 5, 2026, citing an ongoing review of its strategic direction.
Oringer's base salary rose from $1.00 to $1,000,000; he is not eligible for an annual cash bonus for the rest of fiscal 2026 or fiscal 2027
Assi's fixed pay is AUD 775,000 a year, with a target bonus of up to 60% from fiscal 2027, and RSU awards with a target value of $1.5 million
The company will not hold its previously scheduled third quarter 2026 earnings conference call on November 5, 2026
Southern Missouri Bancorp's Chief Financial Officer, Stefan Chkautovich, resigned effective November 7, 2026, to pursue another professional opportunity. The company's President and Chief Administrative Officer, Matthew T. Funke, a former CFO from 2006 to 2022, will become principal financial officer, and the filing says no new compensation arrangements were made for that role.
Chkautovich, CFO since August 31, 2023, informed the company and Southern Bank of his resignation on October 26, 2026, effective November 7, 2026.
Matthew T. Funke, President and Chief Administrative Officer, was appointed principal financial officer upon the resignation taking effect.
Funke and the company did not enter into, and do not anticipate, any compensatory arrangements for the appointment.
At the October 26, 2026 annual meeting, shareholders re-elected or elected directors Rebecca M. Brooks, David L. McClain and Mary Jane Judy to terms ending in 2029, approved the say-on-pay vote, and ratified FORVIS MAZARS, LLP as auditor fo
Summit Hotel Properties appointed Michael Nieves as Executive Vice President and Chief Financial Officer and promoted Adam Wudel to Executive Vice President and Chief Operating Officer, both effective November 1, 2026. Nieves most recently served as Senior Vice President of Finance and Treasurer at PENN Entertainment, and Wudel has been the Company's Executive Vice President of Corporate Development since 2024, so both changes put the Company's finance and operations leadership in new roles at the same time.
Michael Nieves becomes CFO effective November 1, 2026, with a $450,000 base salary and a time-based restricted stock award valued at $750,000.
Adam Wudel becomes COO effective November 1, 2026, with a $450,000 base salary; he has been with the Company since its 2011 IPO.
Both employment agreements run from November 1, 2026 to November 1, 2027, renewing automatically for one-year terms unless either party gives at least 30 days' notice.
PennyMac Financial reported third-quarter 2026 net income of $29 million, or $0.54 per diluted share, down from $182 million a year earlier, while total net revenues fell 26% to $469 million. The company also named Kevin Ryan as its next Chief Financial Officer effective January 1, 2027, succeeding Daniel Perotti, and amended employment agreements with Chairman and CEO David Spector and President Doug Jones. Management said fourth-quarter adjusted return on equity is expected to remain near current levels.
Q3 2026 net income was $29 million, or $0.54 diluted EPS, versus $182 million, or $3.37, in Q3 2025; total net revenues were $469 million, down 26% year over year.
Adjusted diluted EPS was $1.05, down from $1.39 in Q2 2026; production segment posted a $7 million pretax loss.
Kevin Ryan, currently Chief Strategy Officer, becomes CFO on January 1, 2027; Daniel Perotti resigns as CFO effective December 31, 2026 and moves to an advisory role.
Doug Jones, President and Chief Mortgage Banking Officer, is set to retire June 30, 2027; Spector's term runs through December 31, 2031.
Hormel Foods disclosed that John F. Ghingo's employment agreement, which was tied to his role as President and was set to expire December 31, 2026, terminated October 26, 2026 under an October 23, 2026 letter agreement, as he took on the additional role of Chief Executive Officer. The filing says Ghingo now has no specified term as President and CEO, which is a governance detail rather than a change in operations or financial results.
John F. Ghingo began serving as President and Chief Executive Officer effective October 26, 2026, and continues on the Board of Directors.
His prior Employment Agreement, scheduled to expire December 31, 2026, terminated as of October 26, 2026.
The Letter Agreement was entered into October 23, 2026; the filing states he has no specified term as President and CEO.
The full Letter Agreement is expected to be filed as an exhibit to the Form 10-K for the fiscal year ended October 25, 2026.
U.S. Bancorp said Vice Chair and Chief Risk Officer Jodi L. Richard resigned effective immediately to take a position at another publicly traded company, and that the resignation was not due to any disagreement with the company. Executive Vice President and Chief Credit Officer Troy W. Remington will serve as interim Chief Risk Officer while the company selects a successor.
Jodi L. Richard notified the company of her resignation on October 23, 2026, effective immediately
Resignation was not due to any disagreement with the company on operations, policies or practices
Troy W. Remington, Executive Vice President and Chief Credit Officer, is interim Chief Risk Officer
The company has not yet named a permanent successor
The Clorox Company's board appointed Fabian Garcia, currently president of Unilever Personal Care, as chief executive officer effective January 5, 2027. Linda Rendle steps down as CEO and chair on that date and will serve as a senior advisor through April 2, 2027, while Matthew Shattock becomes independent chair. The filing lists Garcia's offer terms, including a $100,000 base salary and an $11,000,000 sign-on RSU award, and the company's first-quarter fiscal 2027 earnings are scheduled for November 2.
Fabian Garcia appointed CEO effective January 5, 2027; he will also join the board
Linda Rendle steps down as CEO and director on January 5, 2027, and advises through April 2, 2027
Matthew Shattock to become independent chair, with a $225,000 chair retainer
Garcia's offer letter includes a $100,000 base salary, $2,000,000 target annual bonus and $11,000,000 one-time sign-on RSU award
Norwegian Cruise Line announced that Meghan Montana, currently Chief Strategy Officer, will become Executive Vice President and Chief Financial Officer on January 1, 2027, replacing Mark Kempa, who moves to a special advisor role through June 30, 2027. The filing sets out Montana's $875,000 base salary and Kempa's transition terms, which matter to shareholders because they mark a change in the leader of the company's finances.
Meghan Montana becomes CFO effective January 1, 2027; her base salary is $875,000 per year.
Mark A. Kempa remains CFO through December 31, 2026, then serves as Special Advisor to the CEO until his separation date of June 30, 2027.
Montana's sign-on bonus totals $1,550,000, with two $400,000 installments payable after March 1, 2027 and March 1, 2028.
Kempa will receive 33,000 time-based restricted share units in early January 2027 in lieu of a prorated 2027 bonus.
Forestar Group's Executive Chairman, Donald J. Tomnitz, will retire effective October 31, 2026, and CEO Anthony W. Oxley will also serve as Executive Chairman from November 1, 2026. Tomnitz will provide advisory services through September 30, 2028 under a monthly fee of $41,667, and the filing also adds director Stacey H. Dwyer and notes that Samuel R. Fuller will not stand for re-election in 2027.
Donald J. Tomnitz retires as Executive Chairman effective October 31, 2026; he had served in the role since October 2017
Anthony W. Oxley, President and CEO, becomes Executive Chairman effective November 1, 2026, a role designated by D.R. Horton, Inc.
Tomnitz's advisory agreement runs through September 30, 2028 at $41,667 per month, with his RSUs and PSUs continuing to vest
Stacey H. Dwyer joins the Board effective November 1, 2026, and Samuel R. Fuller will not be nominated for re-election at the 2027 Annual Meeting
Azora Therapeutics, formerly Adial Pharmaceuticals, appointed Matthew Davidson, Ph.D. as President and Chief Executive Officer effective October 28, 2026, succeeding Cary J. Claiborne, whose employment was terminated. The board also appointed Celia Economides as Chief Financial Officer, succeeding Vinay Shah, and Julie Saiki, Ph.D. as Chief Strategy Officer. Stockholders approved increasing authorized common stock from 100,000,000 to 500,000,000 shares and the name change, with the new ticker AZR expected to begin trading October 29, 2026.
Matthew Davidson, Ph.D. appointed President and CEO effective October 28, 2026; Cary J. Claiborne's employment terminated, subject to a release for severance.
Celia Economides appointed CFO, succeeding Vinay Shah, whose employment was terminated effective October 28, 2026.
Authorized common stock increases from 100,000,000 to 500,000,000 shares; the amendment takes effect 12:01 AM Eastern on October 29, 2026.
Stockholders approved issuance of up to 23,561,896 shares on exercise of milestone pre-funded and incentive warrants, among other proposals.
Effective October 29, 2026, Q2 Holdings named CFO Jonathan Price co-CEO alongside Matthew Flake, who remains president and chairman, and appointed Price to a board expanded from seven to eight members. Price will also keep the CFO role during the company's search for a new CFO, and his pay and severance terms were revised as part of the change.
Effective October 29, 2026, Price becomes co-CEO alongside Flake; the board increases from seven to eight members.
Price's annual base salary rises to $520,000, and he receives an RSU grant valued at $3 million vesting over four years.
Price remains chief financial officer during the search for a new CFO, with no date for that search given in the filing.
Severance is set at 200% of base salary plus a pro-rata bonus, or 250% as a lump sum if terminated within 60 days before to 24 months after a change in control.
Align Technology said Jennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, will become President and CEO on December 31, 2026, replacing Joseph M. Hogan, who has led the company since 2015 and will retire from the role and become a strategic advisor. Davis joins the Board as a director on November 2, 2026, and the filing sets out her pay package, including a $1,300,000 base salary and a $2,000,000 signing bonus. The change marks a planned leadership transition at the company, and the filing discloses no changes to financial results or guidance.
Jennifer L. Davis joins as CEO-elect and director on November 2, 2026, and becomes President and CEO on December 31, 2026
Joseph M. Hogan, CEO since 2015, retires as CEO on December 31, 2026 and will serve as a strategic advisor under a one-year consulting agreement with a $150,000 annual fee
Davis's pay includes a $1,300,000 base salary, a 150% target bonus, equity awards of $9,900,000 and $6,600,000, and a $2,000,000 signing bonus
Board size increases from ten to eleven directors effective November 2, 2026
T-Mobile US said Vice Chair G. Michael Sievert notified the Board on October 26, 2026, that he will resign from the Board and its Transaction Committee effective November 1, 2026, and will also stop serving as Vice Chair. The company said the timing matches the expiration of a September 19, 2025 amendment to his employment agreement, and that the resignation involves no disagreement over operations, policies or practices.
Resignation from the Board and Transaction Committee effective November 1, 2026
Notice to the Board given October 26, 2026
Timing tied to expiration of the September 19, 2025 amendment to his employment agreement
Company states the resignation is not due to any disagreement on operations, policies or practices
Enanta Pharmaceuticals said CEO Jay R. Luly, Ph.D., 70, will retire by February 1, 2027, after 23 years leading the company, and will serve as a strategic advisor for the rest of 2027. The board has started a search for a successor, considering both internal and external candidates, and named Tara L. Kieffer, Ph.D., to the newly created role of Chief Operating Officer. The filing does not include financial results, so the changes are mainly about management succession for shareholders.
Jay R. Luly, Ph.D., age 70, will retire as President and CEO by February 1, 2027, after 23 years with the company
Luly will continue as a strategic advisor for the remainder of 2027; the company expects to enter an agreement for this role
The board is searching for a successor, considering internal and external candidates
Tara L. Kieffer, Ph.D., age 48, was appointed Chief Operating Officer on October 28, 2026; she joined Enanta in 2020 as Chief Product Strategy Officer
Parsons Corporation (NYSE: PSN) said CFO Matt Ofilos will resign effective November 6, 2026, to pursue another professional opportunity, and that his resignation is not due to a disagreement with the company. The board appointed George Ball, a former CFO and current director, as interim CFO on the same date while it searches for a permanent successor.
Matt Ofilos resigns as CFO effective November 6, 2026; the filing says there was no disagreement on operations, policies or practices.
George Ball, CFO from 2008 to 2022 and a board member since 2022, was appointed interim CFO on October 26, 2026, effective November 6, 2026.
Ball will receive a $2.4 million restricted stock unit award that vests on the one-year anniversary, pro-rated for his actual interim service period.
The same-day third-quarter 2026 earnings release reaffirmed the fiscal 2026 revenue and adjusted EBITDA guidance midpoints and narrowed the ranges.
CooperCompanies said Albert G. White III stepped down as President, Chief Executive Officer and director on October 27, 2026, and independent director Walter M. Rosebrough, Jr. was named interim Executive Chair. The press release said the company's recent performance has not met expectations, and the company reaffirmed its fiscal 2026 guidance. Shareholders face a leadership change while a permanent CEO is sought, and the board is changing composition with Shlomo Nachman joining in December 2026 and three directors not seeking reelection.
Albert G. White III resigned as President, CEO and director effective October 27, 2026, and will remain a strategic advisor through April 1, 2027.
Walter M. Rosebrough, Jr. was appointed interim Executive Chair effective immediately; a CEO Search Committee of Lawrence E. Kurzius, Cynthia L. Lucchese and Teresa S. Madden will oversee the CEO search.
Shlomo Nachman will join the board effective December 8, 2026; Barbara Carbone, Colleen E. Jay and Robert S. Weiss will not stand for reelection at the 2027 Annual Meeting.
The company reaffirmed its fiscal 2026 guidance provided on September 9, 2026.
Goodyear said Jerome J. Rouquet, currently CFO of Visteon Corporation, will become Executive Vice President and Chief Financial Officer effective December 1, 2026. Scott M. Deakin continues as Interim CFO through November 30, 2026. The filing also details a compensation package for Rouquet, which includes a base salary of $900,000 and a long-term incentive award valued at $3,200,000.
Jerome J. Rouquet becomes EVP and CFO effective December 1, 2026; Scott M. Deakin serves as interim CFO through November 30, 2026
Rouquet has been SVP and CFO of Visteon Corporation since February 2020; he is 59 years old
Base salary of $900,000 and target annual incentive of $900,000
Make-whole and inducement awards include a $2,500,000 cash payment on March 15, 2027 and Restricted Stock Unit awards of $2,600,000 and $700,000
Visteon said Chief Financial Officer Jerome Rouquet will leave the company effective November 30, 2026, to pursue other opportunities. Colleen Myers, the company's Vice President and Chief Accounting Officer, will serve as interim CFO and principal financial officer while the board searches for a permanent successor. The filing states the departure is not the result of any disagreement over operations, policies, controls or accounting.
Jerome Rouquet, Senior Vice President and CFO, leaves effective November 30, 2026
Colleen Myers, 51, named interim CFO; she has been Chief Accounting Officer since January 2024 and joined Visteon in June 2015
Myers receives a $25,000 monthly stipend while interim CFO; annual base salary rises from $286,000 to $330,000
Axcelis Technologies appointed Jeroen Delsman, formerly a Vice President at Ferrotec USA, as Executive Vice President and Chief Financial Officer effective November 12, 2026, succeeding interim CFO David Ryzhik, who will move to Senior Vice President of Corporate Development and Investor Relations. The filing details a $500,000 base salary and sign-on awards, and notes the appointment is tied to the pending merger with Veeco.
Jeroen Delsman appointed EVP and CFO by the Board on October 24, 2026, effective November 12, 2026
Base salary of $500,000, with a 75% target under the Axcelis Team Incentive plan starting in 2027
Sign-on RSU award with grant date value of $1,200,000, plus a $352,000 sign-on cash bonus and an $80,000 relocation bonus
David Ryzhik moves from interim CFO to Senior Vice President, Corporate Development and Investor Relations, reporting to CEO Russell Low
Hycroft Mining reported third-quarter 2026 results and said it held $211 million in unrestricted cash with no debt, but the filing does not include revenue, earnings or production figures. The company also said CFO Stanton Rideout will move to an advisory role effective March 16, 2027, and that a senior vice president will retire, so shareholders will see a change in finance leadership.
Q3 2026 results: $211 million in unrestricted cash and no debt; the filing gives no revenue, profit or EPS figures
CFO Stanton Rideout moves to Executive Vice President, Strategic Advisor effective March 16, 2027; search for a replacement has started
SVP David Thomas to retire; the 8-K gives March 31, 2027, while the press release gives April 30, 2027
Michael Deal named Chief Operating Officer; four new independent directors appointed
On October 20, 2026, Soren Acquisition Corp. replaced its chief financial officer and changed three of its board seats, with Joseph Tonnos becoming CFO in place of Jamie Weber, who also resigned as a director. Arghavan Di Rezze remains chief executive officer. The filing reports no financial results, and the compensation for the new directors and CFO has not been determined.
Joseph Tonnos was appointed CFO effective October 20, 2026, succeeding Jamie Weber, who resigned as CFO and director.
Spencer Gerrol and Charles N. Kahn III resigned as directors effective October 20, 2026; Roger Cloutier Jr., Austin Criden and Joseph Tonnos filled the three vacancies.
Compensation for the new directors and CFO has not been determined; each is expected to receive an indirect economic interest in founder shares held by sponsor Soren Holdings LLC.
The company furnished an October 26, 2026 press release announcing the appointments as Exhibit 99.1.
Praetorian Acquisition Corp. announced a leadership transition effective October 20, 2026. Peter Ondishin resigned as Chief Financial Officer and director, and Joseph Tonnos was appointed CFO, while three directors resigned and three new independent directors were appointed. Justin Di Rezze, M.D. continues as Chief Executive Officer, and the compensation arrangements for the new directors and CFO have not been determined.
Nicole Seligman, Erica Dorfman and Alex Elias resigned as directors effective October 20, 2026; they also served on the Audit and Compensation Committees.
Peter Ondishin resigned as Chief Financial Officer and director effective October 20, 2026.
Joseph Tonnos was appointed Chief Financial Officer and a Class II director; Roger L. Cloutier Jr., Jimmy Vaiopoulos and Charles P. Garcia were appointed as directors.
Compensation for the new directors and CFO has not been determined; they will enter the Company's standard director indemnity agreement.
Health In Tech appointed Sanjay Shrestha as Chief Executive Officer effective October 20, 2026, succeeding founder Tim Johnson, who became Executive Chairman on the same date. The filing sets out Shrestha's employment terms and restricted stock awards, and part of the equity grant depends on stockholder approval of a plan amendment.
Shrestha, age 52, previously served as a director from April 2025 until his resignation in August 2026.
Base salary is $500,000, increasing to at least $700,000 upon the Company raising at least $10,000,000.
Sign-On Award of 2,000,000 Class A shares; Market Capitalization Awards total 4,500,000 shares.
MC-2, MC-3 and MC-4 tranches (2,500,000 shares) depend on stockholder approval at the November 10, 2026 annual meeting.
Seres Therapeutics said Chief Financial Officer Marella Thorell resigned from her executive vice president and CFO roles on October 22, 2026, effective November 15, 2026. The company said she is expected to provide advisory services after that date to support an orderly transition, on terms still to be agreed.
Marella Thorell resigned as EVP and Chief Financial Officer on October 22, 2026
Resignation takes effect November 15, 2026
Thorell is expected to provide advisory services to support an orderly transition, terms not yet agreed
OpenWorld preliminarily estimated third-quarter 2026 revenue of $6.9 million to $7.2 million and a GAAP net loss of about $10.0 million, which includes about $11.9 million of nonrecurring stock-based compensation and merger-related fees. The company also named Gerard Hernandez Chief Financial Officer effective October 23, 2026, after removing Jennifer Cola from the role. The estimates are unaudited and not yet reviewed by the auditor, and the company will report final results on November 12, 2026.
Estimated Q3 2026 revenue of $6.9 million to $7.2 million, with gross margin of 80% to 82%
Estimated GAAP net loss of about $10.0 million, including about $11.9 million of nonrecurring stock-based compensation and merger-related fees
Estimated adjusted EBITDA (non-GAAP) of $1.7 million to $2.0 million
Gerard Hernandez named CFO effective October 23, 2026; Jennifer Cola was removed as CFO effective the same date
NETSCOUT SYSTEMS filed an 8-K disclosing that Chief Operating Officer Sanjay Munshi resigned from all positions with the company and its subsidiaries on October 22, 2026, effective immediately. The filing does not state a reason for the resignation or name a successor.
Sanjay Munshi, Chief Operating Officer, resigned on October 22, 2026
Resignation covers all positions with the company and its subsidiaries, effective immediately
The filing does not name a replacement or give a reason for the departure
XBiotech's board appointed Dr. Sushma Shivaswamy, who had been interim CEO since December 2025 and remains Chief Scientific Officer, and Jan-Paul Simard as co-chief executive officers effective October 23, 2026. Simard is the son of founder John Simard, and his employment agreement includes a one-time grant of 2,000,000 stock options, which shareholders may weigh alongside the leadership change.
Dr. Sushma Shivaswamy, 48, has been with XBiotech for 17 years and will continue as Chief Scientific Officer with an annual salary of $750,000.
Jan-Paul Simard, 24, joined in 2012; his Executive Employment Agreement is dated October 26, 2026, with a base salary of $150,000, prorated through the end of 2026.
Simard's initial grant is 2,000,000 stock options, exercisable over ten years and vesting over three years in six-month intervals.
MasterBrand said Chief Financial Officer Andrea Simon stopped serving as CFO effective October 23, 2026, and will stay on in a non-executive advisory role until March 31, 2027. Mark Young, the company's Vice President and Chief Accounting Officer, was appointed Interim CFO while keeping his current role, and the company has started a search for a permanent CFO. The filing says Simon's departure is not related to any disagreement or to the integrity of the company's financial statements.
Andrea Simon's CFO role ended October 23, 2026; her advisory period runs through March 31, 2027.
Mark Young, age 49, is Interim CFO and keeps his Vice President and Chief Accounting Officer title.
Young's interim pay includes a $15,000 monthly stipend and a 30% increase in his annual bonus target, plus a one-time $150,000 retention award payable at the 18-month anniversary of his appointment.
Simon's separation agreement includes a $165,900 cash payment, conditioned on her staying through March 31, 2027, in exchange for cancelling her integration restricted stock unit award.
LiveWire Group's chief executive, Karim Donnez, resigned effective October 21, 2026. The board added two directors and formed a Special Restructuring Committee with authority over any financing, sale, restructuring or other strategic transaction, and that committee appointed Roy Gallagher of Ankura Consulting as Chief Restructuring Officer, reporting as the principal executive officer. The filing points to a possible restructuring, though it does not state the company's financial condition or any specific transaction, and it does not report quarterly results.
Karim Donnez resigned as CEO effective October 21, 2026
Roy Gallagher appointed Chief Restructuring Officer effective October 25, 2026; Company pays Ankura a monthly fee of $140,000 for his services
Special Restructuring Committee formed October 22, 2026 with authority over financing, sale, restructuring and other strategic transactions
Third quarter financial results to be released before market hours on October 29, 2026
Herc Holdings said President Aaron Birnbaum will succeed Lawrence Silber as chief executive officer effective January 1, 2027, as part of a planned succession, and Silber, CEO since 2015, will become executive chairman. The filing also sets out the pay the company expects to provide to both executives and names Michael A. Kelly as Lead Director, which shapes how the board will be led after the transition.
Aaron Birnbaum, age 60, becomes CEO and will also remain President; he has been President since January 1, 2026 and was Chief Operating Officer from January 2020 to December 2025
Birnbaum expected annual base salary of $975,000, target bonus of 125% of base salary, and a 2027 long-term equity award with grant date fair value of approximately $4,250,000
Silber expected annual base salary of $600,000, target bonus of 120% of base salary, and a 2027 long-term equity award with grant date fair value of $3,000,000
Michael A. Kelly elected Lead Director and Patrick Campbell moves from Board chairman to independent director, both effective January 1, 2027
FedEx said on October 26, 2026 that Jamere Jackson will become Executive Vice President and Chief Financial Officer effective November 30, 2026, succeeding Claude F. Russ, who has been interim CFO since June 1, 2026. Jackson has been CFO of AutoZone since January 1, 2021, and previously held CFO roles at Hertz and Nielsen Holdings. The filing also discloses his pay package, including a $1,000,000 base salary and a $2,000,000 signing bonus.
Jackson starts as CFO on November 30, 2026, replacing interim CFO Claude F. Russ, who has held the role since June 1, 2026
Jackson's annual base salary is $1,000,000, with a target annual incentive of 120% of eligible earnings paid during TY26
He will receive a $2,000,000 signing bonus in two installments (November 2026 and November 2027) and a one-time special RSU award with a grant date fair value of $5,000,000
Jackson was CFO of AutoZone from January 1, 2021, and CFO of Hertz Global Holdings from 2018 to 2020
AutoZone said Chief Financial Officer Jamere Jackson will resign effective November 25, 2026, to become CFO of FedEx Corporation. The company said the departure is not related to its financial or operating results, and it has started an external search for a successor. Vice President and Controller J. Scott Murphy will serve as principal financial officer and principal accounting officer in the interim.
Jamere Jackson resigned as Chief Financial Officer effective November 25, 2026, notified the company on October 20, 2026.
Jackson will become Chief Financial Officer of FedEx Corporation after leaving AutoZone.
J. Scott Murphy, Vice President and Controller, will serve as principal financial officer and principal accounting officer while the search continues.
CEO Phil Daniele said the company believes it is on track for a solid fiscal 2027.
Game Your Game amended two warrants held by Streeterville Capital, LLC, covering 250,000 and 1,250,000 shares, to reduce the exercise price to $1.00 per share, and Streeterville waived certain trigger provisions in related agreements. The company also appointed Wendy Loundermon as Chief Financial Officer effective October 16, 2026, and raised CEO Soumya Das's base salary and maximum annual bonus. Lower warrant pricing and higher executive pay can affect shareholder value, so both changes merit attention from investors.
Warrants for 250,000 shares (dated March 31, 2026) and 1,250,000 shares (dated June 30, 2026), both issued to Streeterville Capital, LLC, now have a $1.00 exercise price effective as of the Disclosure Date.
Wendy Loundermon was appointed CFO effective October 16, 2026, succeeding Dominic Poole, who remains Vice President of Finance with no compensation change.
Loundermon's agreement provides a $200,000 base salary, a $25,000 signing bonus and stock options on 200,000 shares vesting over 48 months.
CEO Soumya Das's base salary rose from $200,000 to $300,000 effective October 1, 2026, and his maximum annual bonus rose from $50,000 to $200,000.
AMASS Brands said its Chief Financial Officer, Zachary Ament, will resign effective November 16, 2026, and that Geoffrey McFarlane will serve as Interim Chief Financial Officer from November 17, 2026. The filing also reports a revised Series C Preferred Stock certificate that lowers the conversion price floor and a termination of a warrant held by Streeterville Capital, LLC.
CFO Zachary Ament resigned, effective November 16, 2026; the company said the resignation was not due to any disagreement on operations, policies, or financial disclosures.
Geoffrey McFarlane, age 43, was appointed Interim CFO effective November 17, 2026, while the board searches for a permanent CFO.
On October 22, 2026, the Series C Preferred Stock floor price was reduced from $4.00 to $1.00 per share.
The warrant to buy up to 3,500,000 common shares held by Streeterville Capital, LLC was terminated and cancelled, with no payment due from the company.
Ardent Health said its Board found on October 19, 2026 that former CEO Martin J. Bonick failed to fully disclose third-party compensation, and recharacterized his June 2026 separation as a termination for Cause. The company will stop about $4.5 million of unpaid severance and cancel his unvested performance-based restricted stock units, and it reserved its rights to pursue other remedies. The filing says no financial statements or previously disclosed results need revision.
Bonick's employment as President and CEO and his board service ended effective June 2, 2026.
On October 19, 2026, the Board determined that facts discovered after the separation date would have supported a termination for Cause.
Ardent will discontinue about $4.5 million of unpaid cash severance and cancel or forfeit outstanding unvested PRSUs.
The company says none of its financial statements or previously disclosed results need to be revised or corrected.
Freshpet's board committee approved an enhanced compensation package for Nicola Baty, who became President effective October 21, 2026, while continuing as Chief Operating Officer. The package includes a $675,000 base salary, a long-term incentive target of at least 250% of base salary, and restricted stock units covering 58,245 shares that vest in full on June 30, 2029.
Base salary of $675,000 and annual cash bonus target of at least 80% of base salary
Long-term equity incentive target of at least 250% of base salary
RSUs for 58,245 shares under the 2024 Equity Incentive Plan, vesting in full on June 30, 2029, subject to continued employment
Offerpad said Chief Financial Officer Peter Knag will step down effective October 20, 2026, and will stay on as a Senior Advisor through November 30, 2026 to support an orderly transition. Andrew Pieper, the company's Senior Vice President and Controller, was appointed Interim Chief Financial Officer and principal financial and accounting officer. The filing says Knag's departure was not due to any disagreement with the company, and the filing does not discuss financial results.
Peter Knag stepped down as Chief Financial Officer effective October 20, 2026.
Knag remains employed as a Senior Advisor through November 30, 2026.
Andrew Pieper, 44, was appointed Interim Chief Financial Officer effective October 20, 2026.
Knag is eligible for separation payments and benefits under his employment agreement.
LKQ preliminarily reported third-quarter 2026 revenue of $3.32 billion, down from $3.50 billion a year earlier, and a net loss of $16 million to $32 million, compared with net income of $178 million in the third quarter of 2025. The company cited underperformance in Europe, withdrew its full-year 2026 guidance, and replaced CEO Justin Jude with Salvatore A. Abbate, effective December 15, 2026, with an interim Office of the CEO in place until then.
Preliminary Q3 2026 revenue was $3.32 billion versus $3.50 billion in Q3 2025; parts and services organic revenue declined 5.4%.
Diluted loss per share of $0.06 to $0.12 compares with diluted EPS of $0.69 a year earlier; adjusted diluted EPS was $0.47 to $0.53 versus $0.84.
Europe parts and services organic revenue declined 9.8%, and Europe segment EBITDA margin was 4.1% to 5.1%, versus 10.0% a year earlier.
Full-year 2026 guidance, last updated July 30, 2026, is withdrawn; Andy Hamilton left LKQ Europe and Alvarez & Marsal was retained to advise on European operations.
Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm, effective after the filing of its Form 10-Q for the quarter ended September 30, 2026. The filing says the company has not yet engaged a replacement, and it cites multiple previously disclosed material weaknesses in internal control over financial reporting, which the company says were discussed with Forvis Mazars.
Audit Committee and full Board approved the dismissal of Forvis Mazars on October 16, 2026.
Forvis Mazars's reports for fiscal 2025 and 2024 included an explanatory paragraph on substantial doubt about the company's ability to continue as a going concern.
The company reports four material weaknesses, including limited accounting policies, insufficient review and segregation of duties, and information technology general control findings.
No successor auditor had been engaged as of the filing date; Forvis Mazars's letter is dated October 21, 2026 and filed as Exhibit 16.1.
GBank Financial Holdings Inc. said Edward Nigro resigned as Executive Chairman and Chief Executive Officer effective October 22, 2026, as part of a previously approved leadership succession. Jeffrey Newgard, previously President and CEO of GBank, took over as President and CEO of the company and was appointed a director, and Nigro remains a director. The change in top leadership is a significant governance event, and the terms of Newgard's employment agreement have not yet been finalized.
Nigro resigned as Executive Chairman and CEO of the company, and as Executive Chairman and director of GBank, effective October 22, 2026; he will remain a director of the company.
Newgard, age 55, was appointed President, CEO and director of the company; he was previously Chairman, President and CEO of Bank of Idaho from July 2015.
Nigro's separation agreement provides $425,000 annualized from the separation date through the term end date, a pro-rated bonus, 18 months of COBRA premiums, and legal fees up to $10,000.
The company intends to enter a new employment agreement with Newgard, with terms to be disclosed in an amendment to this 8-K.
Kinsale Capital Group's Chief Financial Officer, Bryan P. Petrucelli, will retire from his executive role effective March 2, 2027, and was elected to the Board of Directors on October 22, 2026. Christopher R. Tangard, the company's current Senior Vice President and Chief Accounting Officer, will succeed him as Chief Financial Officer and Treasurer on the same date.
Petrucelli elected to the Board effective October 22, 2026; board size increased from nine to ten members
Petrucelli retires as Executive Vice President, CFO and Treasurer effective March 2, 2027
Tangard, Chief Accounting Officer since March 2024 and at Kinsale since June 2019, becomes CFO and Treasurer on March 2, 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.